Wnt7a interaction with Fzd5 and detection of signaling activation using a split eGFP

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 285-291

  Carmon, Kendra S ^a   Loose, David S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Fzd5; Protein complementation; Split eGFP; Wnt signaling; Wnt7a

Indexed keywords

BETA CATENIN; ENHANCED GREEN FLUORESCENT PROTEIN; FRIZZLED PROTEIN; FRIZZLED PROTEIN 5; UNCLASSIFIED DRUG; WNT PROTEIN; WNT7A PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

FRIZZLED RECEPTORS; GREEN FLUORESCENT PROTEINS; HUMANS; PROTEIN INTERACTION MAPPING; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 39549095427     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.088     Document Type: Article

References (35)

1. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
2. J.R. Miller, The Wnts, Genome Biol. 3 (2002) REVIEWS3001.
3. Kishida S., Yamamoto H., Hino S., Ikeda S., Kishida M., and Kikuchi A. DIX domains of Dvl and Axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol. Cell. Biol. 19 (1999) 4414-4422
4. Tamai K., Zeng X., Liu C.M., Zhang X.J., Harada Y., Chang Z.J., and He X. A mechanism for Wnt coreceptor activation. Mol. Cell 13 (2004) 149-156
5. Itoh K., Krupnik V.E., and Sokol S.Y. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr. Biol. 8 (1998) 591-594
6. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
7. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96 (1999) 5522-5527
8. Ahumada A., Slusarski D.C., Liu X.X., Moon R.T., Malbon C.C., and Wang H.Y. Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298 (2002) 2006-2010
9. Li L., Yuan H.D., Xie W., Mao J.H., Caruso A.M., McMahon A., Sussman D.J., and Wu D.Q. Dishevelled proteins lead to two signaling pathways-regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J. Biol. Chem. 274 (1999) 129-134
10. Nusse R., and Varmus H.E. Many tumors induced by the mouse mammary-tumor virus contain a provirus integrated in the same region of the host genome. Cell 31 (1982) 99-109
11. Morin P.J. Beta-catenin signaling and cancer. Bioessays 21 (1999) 1021-1030
12. Nakamura Y., Nishisho I., Kinzler K.W., Vogelstein B., Miyoshi Y., Miki Y., Ando H., Horii A., and Nagase H. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors. Princess Takamatsu Symp. 22 (1991) 285-292
13. Prat J., Gallardo A., Cuatrecasas M., and Catasus L. Endometrial carcinoma: pathology and genetics. Pathology (Phila) 39 (2007) 72-87
14. Aguilera O., Fraga M.F., Ballestar E., Paz M.F., Herranz M., Espada J., Garcia J.M., Munoz A., Esteller M., and Gonzalez-Sancho J.M. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25 (2006) 4116-4121
15. Liu T.H., Raval A., Chen S.S., Matkovic J.J., Byrd J.C., and Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res. 66 (2006) 653-658
16. Nojima M., Suzuki H., Toyota M., Watanabe Y., Maruyama R., Sasaki S., Sasaki Y., Mita H., Nishikawa N., Yamaguchi K., Hirata K., Itoh F., Tokino T., Mori M., Imai K., and Shinomura Y. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 26 (2007) 4699-4713
17. Barker N., and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5 (2006) 997-1014
18. Miller C., and Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125 (1998) 3201-3211
19. Miller C., Pavlova A., and Sassoon D.A. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech. Dev. 76 (1998) 91-99
20. Bui T.D., Lako M., Lejeune S., Curtis A.R., Strachan T., Lindsay S., and Harris A.L. Isolation of a full-length human WNT7A gene implicated in limb development and cell transformation, and mapping to chromosome 3p25. Gene 189 (1997) 25-29
21. Hirabayashi Y., Itoh Y., Tabata H., Nakajima K., Akiyama T., Masuyama N., and Gotoh Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 131 (2004) 2791-2801
22. Caricasole A., Ferraro T., Iacovelli L., Barletta E., Caruso A., Melchiorri D., Terstappen G.C., and Nicoletti F. Functional characterization of WNT7A signaling in PC12 cells - Interaction with a FZD5 center dot LRP6 receptor complex and modulation by dickkopf proteins. J. Biol. Chem. 278 (2003) 37024-37031
23. Dann C.E., Hsieh J.C., Rattner A., Sharma D., Nathans J., and Leahy D.J. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412 (2001) 86-90
24. Mikels A.J., and Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 4 (2006) 570-582
25. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., and Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
26. Wu C.H., and Nusse R. Ligand receptor interactions in the Wnt signaling pathway in Drosophila. J. Biol. Chem. 277 (2002) 41762-41769
27. Campbell-Valois F.X., and Michnick S.W. Synthesis of degenerated libraries of the ras-binding domain of raf and rapid selection of fast-folding and stable clones with the dihydrofolate reductase protein fragment complementation assay. Methods Mol. Biol. 352 (2007) 249-274
28. Ding Z., Liang J., Lu Y., Yu Q., Songyang Z., Lin S.Y., and Mills G.B. A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc. Natl. Acad. Sci. USA 103 (2006) 15014-15019
29. Galarneau A., Primeau M., Trudeau L.E., and Michnick S.W. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions. Nat. Biotechnol. 20 (2002) 619-622
30. Ghosh I., Hamilton A.D., and Regan L. Antiparallel leucine zipper-directed protein reassembly: application to the green fluorescent protein. J. Am. Chem. Soc. 122 (2000) 5658-5659
31. Luker K.E., Smith M.C.P., Luker G.D., Gammon S.T., Piwnica-Worms H., and Piwnica-Worms D.P. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. USA 101 (2004) 12288-12293
32. Nyfeler B., Michnick S.W., and Hauri H.P. Capturing protein interactions in the secretory pathway of living cells. Proc. Natl. Acad. Sci. USA 102 (2005) 6350-6355
33. Paulmurugan R., Umezawa Y., and Gambhir S.S. Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc. Natl. Acad. Sci. USA 99 (2002) 15608-15613
34. Zhang S., Ma C., and Chalfie M. Combinatorial marking of cells and organelles with reconstituted fluorescent proteins. Cell 119 (2004) 137-144
35. 2+ flux, PKC, and CamKII in vertebrate embryos. J. Cell Biol. 161 (2003) 769-777